Magnetic Resonance-guided Focused Ultrasound (MRgFUS) offers an incision-free pathway for treating Parkinson’s disease and Essential Tremor, yet its adoption in India remains limited. Understanding MRgFUS as a Non-Invasive Alternative For patients facing the physical toll of Parkinson’s disease or Essential Tremor, traditional surgical options often involve significant risks, such as incisions or drilling into the … Read more
Women diagnosed with Parkinson’s disease exhibit a higher amyloid plaque burden in the brain compared to men, according to a study led by the Mayo Clinic Arizona. While men with Parkinson’s are generally at a higher risk of developing dementia, this new research indicates that women harbor more Alzheimer’s-related protein deposits, even when adjusting for … Read more
A multi-institutional research team led by the Indiana University School of Medicine has secured a $9 million grant to investigate how immune cell aging contributes to the onset and progression of Parkinson’s disease. The project, supported by Aligning Science Across Parkinson’s (ASAP) and The Michael J. Fox Foundation for Parkinson’s Research, will examine immune-cell exhaustion … Read more
Researchers at UC San Francisco have developed a personalized adaptive deep brain stimulation (aDBS) system that automatically adjusts in real time to stabilize gait in patients with Parkinson’s disease. Published in Nature Medicine, the study shows that an implanted neurostimulator can detect neural signals linked to individual steps and modulate therapy within fractions of a … Read more
Researchers at the Ecole Polytechnique Federale de Lausanne (EPFL) have developed an artificial intelligence-driven deep brain stimulation (DBS) system that automatically adjusts to a patient’s movement in real time. According to a study published in Nature Medicine, this technology improves mobility for Parkinson’s disease patients by decoding neural biomarkers to modulate electrical pulses during activities … Read more
Researchers at the Federal University of São Paulo (UNIFESP) have identified a potential new pathway to protect neurons from Parkinson’s disease by targeting neuroinflammation rather than dopamine replacement. Published in the journal Neuropharmacology, the study shows that the peptide Ac2-26, derived from the protein Annexin A1, reduces neuronal degeneration in mice by mitigating the inflammatory … Read more
The Digital Renaissance: How AI is Breaking Barriers for Musicians with Disabilities For decades, the image of the songwriter has been synonymous with the physical act of playing: fingers dancing across a fretboard or hands gliding over piano keys. But what happens when that physical connection is severed by neurological illness? For London-based songwriter Samuel … Read more
Beyond the Mitochondria: The New Metabolic Frontier in the Fight Against Parkinson’s Disease For decades, the scientific community has viewed Parkinson’s disease (PD) through a relatively narrow lens: mitochondrial dysfunction. The prevailing wisdom suggested that the breakdown of the cell’s “powerhouse” was the primary driver of neuronal death. However, a paradigm shift is underway. New … Read more
A New Frontier in Early Detection: The Immuno-Infrared Sensor For years, the medical community has faced a daunting challenge: by the time symptoms of Alzheimer’s or Parkinson’s disease manifest, the brain has often suffered irreversible damage. Modern diagnostic approaches are largely symptom-oriented, which frequently delays essential intervention. However, a breakthrough in blood-based diagnostics may soon … Read more
The New Era of Parkinson’s Care: Moving Beyond the Diagnosis For decades, the conversation around Parkinson’s disease (PD) has been dominated by the “visible” symptoms—the tremors, the rigidity, and the slow movement. But a paradigm shift is occurring. We are moving away from a purely pharmacological approach toward a holistic, multi-faceted model of care that … Read more